For help on how to get the results you want, see our search tips.
303 results
Keyword Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Ablavar (previously Vasovist)
gadofosveset trisodium, Magnetic Resonance Angiography
Date of authorisation: 03/10/2005, Revision: 10, Withdrawn, Last updated: 14/11/2011 -
List item
Human medicine European public assessment report (EPAR): Acomplia
rimonabant, Obesity
Date of authorisation: 19/06/2006, Revision: 8, Withdrawn, Last updated: 30/01/2009 -
List item
Veterinary medicine European public assessment report (EPAR): Advasure
E2 glycoprotein of classical swine fever virus, Pigs
Date of authorisation: 02/02/2001, Revision: 5, Withdrawn, Last updated: 17/03/2008 -
List item
Human medicine European public assessment report (EPAR): Aerivio Spiromax
salmeterol xinafoate, fluticasone propionate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 15/01/2020 -
List item
Human medicine European public assessment report (EPAR): Agenerase
amprenavir, HIV Infections
Date of authorisation: 20/10/2000, Revision: 18, Withdrawn, Last updated: 21/06/2011 -
List item
Human medicine European public assessment report (EPAR): Airexar Spiromax
salmeterol, fluticasone propionate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 02/07/2019 -
List item
Human medicine European public assessment report (EPAR): Alisade
fluticasone furoate, Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Seasonal
Date of authorisation: 06/10/2008, Revision: 4, Withdrawn, Last updated: 18/10/2011 -
List item
Human medicine European public assessment report (EPAR): Allex
desloratadine, Rhinitis, Allergic, Perennial, Urticaria, Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Withdrawn, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Alpivab
Peramivir, Influenza, Human
Date of authorisation: 13/04/2018,
, Revision: 2, Withdrawn, Last updated: 09/12/2020
-
List item
Human medicine European public assessment report (EPAR): Altargo
retapamulin, Impetigo, Staphylococcal Skin Infections
Date of authorisation: 24/05/2007, Revision: 15, Withdrawn, Last updated: 15/03/2019 -
List item
Human medicine European public assessment report (EPAR): Angiox
Bivalirudin, Acute Coronary Syndrome
Date of authorisation: 20/09/2004, Revision: 22, Withdrawn, Last updated: 14/09/2018 -
List item
Human medicine European public assessment report (EPAR): Arepanrix
split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs., Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 23/03/2010,
, Revision: 1, Withdrawn, Last updated: 25/10/2011
-
List item
Human medicine European public assessment report (EPAR): Ariclaim
duloxetine, Diabetic Neuropathies
Date of authorisation: 11/08/2004, Revision: 26, Withdrawn, Last updated: 07/08/2018 -
List item
Human medicine European public assessment report (EPAR): Arzerra
ofatumumab, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 19/04/2010, Revision: 16, Withdrawn, Last updated: 10/05/2019 -
List item
Human medicine European public assessment report (EPAR): ATryn
Antithrombin alfa, Antithrombin III Deficiency
Date of authorisation: 28/07/2006,, 
, Revision: 16, Withdrawn, Last updated: 02/07/2019
-
List item
Human medicine European public assessment report (EPAR): Avaglim
rosiglitazone, glimepiride, Diabetes Mellitus, Type 2
Date of authorisation: 27/06/2006, Revision: 11, Withdrawn, Last updated: 12/08/2011 -
List item
Human medicine European public assessment report (EPAR): Avandamet
rosiglitazone, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 20/10/2003, Revision: 16, Withdrawn, Last updated: 08/06/2016 -
List item
Human medicine European public assessment report (EPAR): Avandia
rosiglitazone, Diabetes Mellitus, Type 2
Date of authorisation: 11/07/2000, Revision: 23, Withdrawn, Last updated: 08/06/2016 -
List item
Human medicine European public assessment report (EPAR): Bextra
valdecoxib, Arthritis, Rheumatoid, Osteoarthritis, Dysmenorrhea
Date of authorisation: 27/03/2003, Revision: 2, Withdrawn, Last updated: 03/02/2010 -
List item
Human medicine European public assessment report (EPAR): BindRen
colestilan, Hyperphosphatemia
Date of authorisation: 21/01/2013,, Revision: 2, Withdrawn, Last updated: 01/04/2015
-
List item
Human medicine European public assessment report (EPAR): Biograstim
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 15/09/2008,
, Revision: 8, Withdrawn, Last updated: 19/01/2017
-
List item
Human medicine European public assessment report (EPAR): Bondenza (previously Ibandronic Acid Roche)
ibandronic acid, Osteoporosis, Postmenopausal
Date of authorisation: 23/02/2004, Revision: 16, Withdrawn, Last updated: 13/05/2013 -
List item
Veterinary medicine European public assessment report (EPAR): Bovalto Ibraxion
inactivated IBR virus, Cattle
Date of authorisation: 09/03/2000, Revision: 10, Withdrawn, Last updated: 13/08/2019 -
List item
Veterinary medicine European public assessment report (EPAR): BTVPUR AlSap 1
bluetongue-virus serotype-1 antigen, Sheep, Cattle
Date of authorisation: 17/12/2010, Revision: 4, Withdrawn, Last updated: 17/05/2018 -
List item
Veterinary medicine European public assessment report (EPAR): BTVPUR AlSap 2-4
bluetongue-virus serotype-2 antigen, bluetongue-virus serotype-4 antigen, Sheep
Date of authorisation: 04/11/2010, Revision: 4, Withdrawn, Last updated: 13/11/2018